MiceYoung (2–4 months old) and old (18–26 months old) male and female wild-type C57BL6/J, Lgr5-ki-eGFP-creER, and Olfm4-ki-eGFP-creER mice were group housed and maintained in...
September 29, 2023 South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine,...
Tzioupis, C. & Giannoudis, P. V. Prevalence of long-bone non-unions. Injury 38, S3–S9 (2007).Article PubMed Google Scholar Calori, G. M., Mazza, E., Colombo,...
Acute platelet depletion rapidly recruits quiescent HSCs into proliferationIn line with previous studies9, administration of a single dose of anti-GPIbα antibody to Vwf-GFP mice,...
BrainStorm Cell Therapeutics is developing Nurown, an investigational therapy intended for treating ALS.
I recently posted about BrainStorm and its prospects for providing real hope...
Dive Brief:
The Novo Nordisk Foundation, the controlling owner of the Danish drugmaker, will spend up to 950 million kroner, or roughly $136 million, to...
The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers....
